Molecular Profiling in mHSPC: Informing Treatment Selection
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Winning the Battle Against Side Effects: Adverse Event Management in HSPC
De Novo mHSPC: Recognizing the Patients Who Need More
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
July 08, 2026
06:00 PM - 07:30 PM ET
Partnering Through Treatment: Preparing for Immunotherapy in the Perioperative Setting
Jennifer Johnson, MD, PhD
Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy
Adam J. Luginbuhl, MD
Choosing the Path Forward: A Real-World Dialogue on Perioperative Immunotherapy
Talking Through Treatment: Patient–Clinician Dialogue on Perioperative Immunotherapy in Locally Advanced HNSCC
All Hands on Deck: Multidisciplinary Coordination for Smarter Perioperative Care
Brain Metastases Management: From Detection to Multidisciplinary Care
Barbara O'Brien, MD
Inside the Decision: Case-Based Navigation of Brain Metastases in Breast and Lung Cancer
Benjamin Levy, MD
Melin Khandekar, MD, PhD
Nadia Harbeck, MD, PhD
Sequencing Systemic and Local Therapy in HER2-Overexpressing Metastatic NSCLC
Managing Brain Metastases Through Multidisciplinary Team Collaboration
First-Line Management of HR+/HER2-Low Breast Cancer With Brain Metastases
EGFR-Mutated NSCLC With Brain Metastases: Navigating ADC Treatment Decisions
Living With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
Cem Akin, MD, PhD
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.